{"transactions":[{"id":1328852,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-18T01:36:30.000Z","date":"2024-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":7856,"price":16.08,"value":126324.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":87518,"source":{"system":"sec-edgar","filing":"0001724521-24-000181","document":"wk-form4_1734485783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452124000181/wk-form4_1734485783.xml","form_type":"4"}},{"id":1405141,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-09-17T22:42:08.000Z","date":"2024-09-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5385,"price":17.95,"value":96660.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,123 shares purchased on 5/31/2024 through the Company's Employee Stock Purchase Plan."}],"balance_after":94933,"source":{"system":"sec-edgar","filing":"0001724521-24-000149","document":"wk-form4_1726612922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452124000149/wk-form4_1726612922.xml","form_type":"4"}},{"id":1670960,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-26T00:38:55.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":113700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in 48 equal monthly installments after January 1, 2024, subject to the Reporting Person's continued service to the Company."}],"balance_after":113700,"derivative":{"exercise_price":15.44,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":113700},"source":{"system":"sec-edgar","filing":"0001724521-24-000024","document":"wk-form4_1706229520.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452124000024/wk-form4_1706229520.xml","form_type":"4"}},{"id":1670959,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-26T00:38:55.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2024, subject to the Reporting Person's continued service to the Company."}],"balance_after":99195,"source":{"system":"sec-edgar","filing":"0001724521-24-000024","document":"wk-form4_1706229520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452124000024/wk-form4_1706229520.xml","form_type":"4"}},{"id":1703393,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-20T21:10:40.000Z","date":"2023-12-19","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":1540,"price":18.09,"value":27858.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.78 to $18.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":71195,"source":{"system":"sec-edgar","filing":"0001724521-23-000069","document":"wk-form4_1703106628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452123000069/wk-form4_1703106628.xml","form_type":"4"}},{"id":1703392,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-20T21:10:40.000Z","date":"2023-12-18","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":1507,"price":17.74,"value":26734.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.45 to $17.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 651 shares purchased on 11/30/2023 through the Company's Employee Stock Purchase Plan."}],"balance_after":72735,"source":{"system":"sec-edgar","filing":"0001724521-23-000069","document":"wk-form4_1703106628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452123000069/wk-form4_1703106628.xml","form_type":"4"}},{"id":1776256,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-20T20:47:46.000Z","date":"2023-09-18","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":3708,"price":20.4,"value":75643.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 799 shares purchased on 5/31/2023 through the Company's Employee Stock Purchase Plan."}],"balance_after":73591,"source":{"system":"sec-edgar","filing":"0001724521-23-000008","document":"wk-form4_1695242857.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452123000008/wk-form4_1695242857.xml","form_type":"4"}},{"id":2046435,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-25T22:55:09.000Z","date":"2023-01-23","kind":"grant","acquired":true,"shares":138200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company."}],"balance_after":138200,"derivative":{"exercise_price":22.02,"expiration_date":"2033-01-22","underlying":"Common Stock","underlying_shares":138200},"source":{"system":"sec-edgar","filing":"0001209191-23-004876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919123004876/doc4.xml","form_type":"4"}},{"id":2046434,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-25T22:55:09.000Z","date":"2023-01-23","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company."}],"balance_after":76500,"source":{"system":"sec-edgar","filing":"0001209191-23-004876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919123004876/doc4.xml","form_type":"4"}},{"id":2174985,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-24T20:08:36.000Z","date":"2022-08-23","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable in 48 equal monthly installments after August 1, 2022, subject to the Reporting Person's continued service to the Company."}],"balance_after":170000,"derivative":{"exercise_price":26,"expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001209191-22-047316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919122047316/doc4.xml","form_type":"4"}},{"id":2174984,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-08-24T20:08:36.000Z","date":"2022-08-23","kind":"grant","acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in four equal annual installments beginning September 15, 2023, subject to the Reporting Person's continued service to the Company."}],"balance_after":42500,"source":{"system":"sec-edgar","filing":"0001209191-22-047316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919122047316/doc4.xml","form_type":"4"}},{"id":3061806,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-08-11T16:06:50.000Z","date":"2020-08-07","kind":"sale","acquired":false,"shares":3538,"price":2.5541,"value":9036.4058,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.48 to $2.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":8462,"source":{"system":"sec-edgar","filing":"0001567619-20-014729","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000156761920014729/doc1.xml","form_type":"4"}},{"id":3123809,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-06-03T17:26:46.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,000 RSUs.  The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the adjusted total which includes the purchase of 2,000 shares under the Employee Stock Purchase Plan on May 15, 2020."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001567619-20-011635","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000156761920011635/doc1.xml","form_type":"4"}},{"id":3252780,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-24T18:28:47.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of February 21, 2020."}],"balance_after":250000,"derivative":{"exercise_price":3.65,"expiration_date":"2030-02-20","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001567619-20-004745","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000156761920004745/doc1.xml","form_type":"4"}},{"id":3525913,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":84983,"kind":"person","name":"Nuyten Dimitry SA","position":1,"cik":"0001776564","reported_name":"Nuyten Dimitry SA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Initial Option Grant","published_at":"2019-05-15T19:02:22.000Z","date":"2019-05-13","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the initial option grant vest 1/4 after the first year, the remaining shares will vest monthly over 36 months."}],"balance_after":400000,"derivative":{"exercise_price":2.98,"expiration_date":"2029-05-12","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001567619-19-011351","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000156761919011351/doc1.xml","form_type":"4"}}]}